gemcitabine has been researched along with Granulocytic Leukemia, Chronic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abbe, P; Benhida, R; Cavazza, E; Cerezo, M; Jaune, E; Millet, A; Plaisant, M; Rocchi, S; Ronco, C | 1 |
| Björn, N; Gréen, H; Jakobsen, I; Lotfi, K | 1 |
| Björn, N; Gréen, H; Pellé, L; Schimek, V; Svedberg, A | 1 |
| Han, XF; Ling, Z; Liu, D; Liu, LX; Liu, YF; Sun, L; Wang, F | 1 |
| Geisen, F; Konwalinka, G; Schirmer, M; Tiefenthaler, M | 1 |
| Korycka, A; Lech-Maranda, E; Robak, T | 2 |
| Adams, DJ; Bass, AJ; Davis, P; DeCastro, CM; Foster, T; Gockerman, JP; Hurwitz, H; Jacobson, R; Laughlin, MJ; Moore, JO; Petros, WP; Rizzieri, DA; Rosner, GL | 1 |
| Gandhi, V; Heinemann, V; Huang, P; Plunkett, W; Xu, YZ | 1 |
1 trial(s) available for gemcitabine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.
Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mitoxantrone; Neural Tube Defects | 2002 |
8 other study(ies) available for gemcitabine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Discovery and Optimization of N-(4-(3-Aminophenyl)thiazol-2-yl)acetamide as a Novel Scaffold Active against Sensitive and Resistant Cancer Cells.
Topics: Acetamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Mice; Pancreatic Neoplasms; Structure-Activity Relationship; Thiazoles | 2016 |
Single-Cell RNA Sequencing of Hematopoietic Stem and Progenitor Cells Treated with Gemcitabine and Carboplatin.
Topics: Carboplatin; Cell Cycle; Cells, Cultured; Deoxycytidine; Gemcitabine; Gene Expression; Gene Ontology; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; RNA-Seq; Sequence Alignment; Single-Cell Analysis | 2020 |
JMJD1C knockdown affects myeloid cell lines proliferation, viability, and gemcitabine/carboplatin-sensitivity.
Topics: Carboplatin; Cell Proliferation; Cell Survival; Deoxycytidine; Gemcitabine; Gene Knockdown Techniques; Humans; Jumonji Domain-Containing Histone Demethylases; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myeloid Cells; Oxidoreductases, N-Demethylating | 2021 |
[Effect of gemcitabine on granulocyte colony-stimulating factor receptor and bcr/abl mRNA in patients with chronic myeloid leukemia].
Topics: Adolescent; Adult; Bone Marrow; Case-Control Studies; Deoxycytidine; Fusion Proteins, bcr-abl; Gemcitabine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Receptors, Granulocyte Colony-Stimulating Factor; RNA, Messenger; Tumor Cells, Cultured; Young Adult | 2010 |
Differential effects of cladribine and gemcitabine on erythroid and granulocytic progenitors from patients with chronic myeloid leukemia.
Topics: Antimetabolites, Antineoplastic; Bone Marrow Cells; Bone Marrow Purging; Cells, Cultured; Cladribine; Deoxycytidine; Deoxycytidine Kinase; Gemcitabine; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells | 1999 |
The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Culture Techniques; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Leukemia, Experimental; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred Strains; Stem Cells; Tumor Cells, Cultured | 2000 |
Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Culture Techniques; Cell Division; Cladribine; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Stem Cells | 2000 |
Metabolism and action of 2',2'-difluorodeoxycytidine: self-potentiation of cytotoxicity.
Topics: Arabinofuranosylcytosine Triphosphate; Base Sequence; Cell Line; Cell Survival; DCMP Deaminase; Deoxycytidine; Deoxycytosine Nucleotides; Deoxyribonucleotides; DNA Polymerase II; Gemcitabine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Sequence Data; Oligodeoxyribonucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Stem Cell Assay | 1991 |